SNDX
SNDX
NASDAQ · Biotechnology

Syndax Pharmaceuticals Inc

$18.07
+0.45 (+2.55%)
As of Sep 21, 10:01 PM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +35.5% upside
Low Target $15.15
Average Target $24.49
High Target $32.88
Current Price $18.07
Current
$18.07
Target
$24.49
$15.15 $24.49 avg $32.88
Scenario Analysis
Bear Case
$15.15
-16.2%
Low target
Base Case
$24.49
+35.5%
Avg target
Bull Case
$32.88
+82.0%
High target
Risk/Reward
5.1x
Highly favorable
Price in Context
52-Week High
$25.59
-29.4% from high
52-Week Low
$12.99
+39.1% from low
50-Day SMA
$20.42
-11.5% vs SMA
RSI (14)
34.3
Neutral
Target vs 52W High
$24.49
-4.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%